The Vanguard Group 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:13 pm Purchase |
2023-12-29 | 13G | Revolution Medicines, Inc. RVMD |
The Vanguard Group | 14,634,391 8.930% |
7,072,481 (+93.53%) |
Filing |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Revolution Medicines, Inc. RVMD |
The Vanguard Group | 7,561,910 8.520% |
1,262,301 (+20.04%) |
Filing |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
The Vanguard Group | 6,299,609 8.550% |
2,261,789 (+56.02%) |
Filing |
| 2021-02-10 11:47 am Purchase |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
The Vanguard Group | 4,037,820 6.080% |
4,037,820 (New Position) |
Filing |